Fecal Calprotectin vs. Lactoferrin in the Endurance Athlete GI Workup: What the Sports RD Should Order, How to Read the Paired-Marker Pattern Against Training Load, and the SOAP Documentation Structure That Prevents Both the Missed IBD Diagnosis and the Unnecessary Scope Referral

A 41-year-old female masters trail runner in week 14 of an 18-week ultramarathon build presents with three weeks of intermittent bright-red streaking on the toilet paper after long-run days, worsening lower-abdominal cramping in the final 90 minutes of any run past 3 hours, and two episodes of frank urgency during a race simulation that forced her off-course. Her primary ordered a CBC, CMP, hs-CRP, and stool guaiac. Everything returned within reference. The primary sent her home with a note that read "likely exercise-associated, follow up if worsening."

The primary's read is not obviously wrong. Bloody streaking after ultra-distance running is a documented phenomenon — the classic "runner's colitis" story — driven by transient mesenteric ischemia during redistribution of splanchnic blood flow, gut-wall permeability that opens under heat and effort load, and mechanical jostling of the cecum against the anterior abdominal wall.

But the standard panel does not distinguish exercise-induced permeability from an actual inflammatory bowel process that the training load is aggravating. That distinction is where the athlete's care plan lives. Fecal calprotectin and fecal lactoferrin are the two neutrophil-derived stool markers that let a sports RD, in coordination with the ordering physician, get that read before the athlete either loses the season to a missed IBD diagnosis or gets scoped for an exercise-induced pattern that a nutrition intervention would have resolved in six weeks.

What Calprotectin Actually Measures

Calprotectin is a calcium-and-zinc-binding cytosolic protein produced by neutrophils, monocytes, and macrophages. Roughly 60 percent of neutrophil cytosolic protein content is calprotectin. When neutrophils cross the intestinal epithelium during active inflammation — as they do in IBD, in NSAID enteropathy, in bacterial gastroenteritis — they either release calprotectin actively or shed it as they lyse in the lumen. The protein is resistant to bacterial degradation and stable in stool at room temperature for up to 7 days. That stability is why it works as a mail-in assay.

The signal is not diagnostic of any specific disease. It is a quantitative readout of neutrophil traffic across the epithelium in the preceding 24–72 hours. A value of 50 μg/g stool is quiet. A value of 500 is loud. A value of 2,500 is a scope referral. The interpretive framework matters more than the absolute number.

What Lactoferrin Adds

Lactoferrin is an iron-binding glycoprotein released from neutrophil secondary granules during degranulation. Unlike calprotectin, which reflects both active release and lytic shedding, lactoferrin reflects only active degranulation — meaning it tracks acute neutrophilic activity more tightly than long-tail cellular turnover.

In practice this makes lactoferrin the more responsive marker for acute inflammatory events and calprotectin the more sensitive marker for chronic, low-grade inflammation. Studies pairing both markers in IBD workups consistently show calprotectin catching more subclinical activity while lactoferrin drops faster after clinical remission is achieved. For a sports RD reading a workup, this pairing gives two independent lines of evidence: is there neutrophilic traffic across the epithelium (calprotectin), and is that traffic acutely active right now (lactoferrin)?

The two markers correlate but do not overlap perfectly. An athlete with an elevated calprotectin and a normal lactoferrin has a very different clinical picture from one with both elevated — the first suggests a chronic low-grade or resolving process, the second suggests active degranulation the RD needs to escalate immediately.

The Reference Bands That Actually Matter

The manufacturer reference for fecal calprotectin (ELISA methods; Bühlmann and PhiCal are the most common) sits at:

• Under 50 μg/g — normal, no active mucosal neutrophil traffic detectable
• 50–120 μg/g — indeterminate, often reported as "borderline"
• 120–250 μg/g — mild elevation
• Over 250 μg/g — moderate to marked elevation; IBD workup indicated

The general-population thresholds are not the athlete reference. Endurance training raises baseline fecal calprotectin in the absence of any inflammatory pathology. Studies in elite marathoners, ultra-endurance triathletes, and cyclists during heavy training blocks routinely report resting fecal calprotectin values in the 50–150 μg/g range in athletes with no GI complaints and no other markers of inflammation. Post-race samples drawn 24 hours after a marathon or longer commonly land at 400–1000 μg/g in otherwise-well-recovered athletes and normalize within 5–7 days.

The clinical rule I use with the sports physicians who order these panels: timing matters more than the number. A single fecal calprotectin sample drawn 48 hours after a long run in an ultra-endurance athlete tells you almost nothing on its own. The same sample drawn 5–7 days after the last high-load session, with the athlete in an active recovery block and no other GI insult in the interim, is the sample that can actually distinguish exercise-associated permeability from an inflammatory floor that persists between training bouts.

For fecal lactoferrin, the reference floor is roughly under 7.24 μg/mL by semi-quantitative immunoassay, or under 100 ng/mL by quantitative ELISA depending on the platform. Elevations track more tightly to acute inflammation and clear faster after resolution than calprotectin, which is why pairing the two is the discriminating move.

The Sports RD's Paired-Marker Read

The interpretive framework for a paired calprotectin-plus-lactoferrin workup in an endurance athlete with recurrent GI complaints, all samples drawn 5–7 days after last high-load session:

Both markers within reference. Exercise-associated GI symptoms with no detectable inflammatory floor. Nutrition intervention lane: pre-race gut training (repeated carbohydrate-tolerance sessions), FODMAP restriction in the 48 hours before hard efforts, cold pre-cooling to reduce splanchnic ischemia risk, and — critically — a documented plan that does not include escalation unless symptoms progress. Re-measure in 6–8 weeks or after any new symptom escalation.

Calprotectin elevated, lactoferrin within reference. Low-grade or chronic mucosal neutrophil traffic without acute degranulation activity. This is the most ambiguous pattern in the athlete population and the one where sports RD experience shows up. Possibilities: (a) NSAID enteropathy from recovery-phase ibuprofen or naproxen use — quantify the athlete's NSAID intake over the prior 6 weeks with specificity, not just "sometimes"; (b) subclinical IBD in an athlete whose training-induced anti-inflammatory effect is masking the clinical picture; (c) resolving post-infectious enteritis; (d) chronic elevation from a training pattern that has never allowed a true washout. The escalation call belongs to the ordering physician, but the RD's Assessment should document each of these hypotheses with the evidence for and against.

Both markers elevated. Active neutrophilic inflammation. The scope referral is non-negotiable. The RD's role shifts from workup to co-management planning — anti-inflammatory dietary pattern (Mediterranean or specific-carbohydrate depending on the physician's read), iron and B12 monitoring given the malabsorption risk, and a documented pause on any high-heat or long-duration training that would further stress the barrier. The nutrition plan does not replace GI evaluation. It bridges the gap between the flag and the biopsy.

Calprotectin within reference, lactoferrin elevated. Rare pattern. Acute neutrophilic activity without chronic mucosal traffic. Consider recent bacterial gastroenteritis, C. difficile in a recently antibiotic-exposed athlete, or a laboratory pre-analytic error. Repeat both markers in 2 weeks with attention to the sample handling chain and confirm the athlete has not had a symptomatic GI event in the interim.

The Athlete-Specific Timing Discipline

The single most common failure I see in sports GI workups is the sample drawn on the wrong day. An athlete emails their symptoms on Tuesday, the primary orders the calprotectin, the athlete drops the sample on Wednesday — which is 72 hours after Sunday's 4-hour long run. The result comes back at 420 μg/g. The primary reads that as "elevated, consider IBD workup." The athlete gets scheduled for a colonoscopy that would have been avoided if the sample had been timed to a mid-recovery window.

The discipline is to build the sample timing into the ordering conversation with the physician. Two samples, spaced 7–10 days apart, both drawn at least 96 hours after the last high-load session, both accompanied by a training log entry documenting the preceding 7 days of load, hydration, NSAID use, and dietary changes. A single value is a rumor. A paired value with documented context is a signal.

For an athlete in an active heavy-training block where a true washout is impossible without derailing the season, coordinate with the physician on either (a) a short deload for the workup sample or (b) accepting the exercise-elevated baseline as the interpretive floor and moving forward only on values above the athlete's own established resting-in-training range. Document that decision explicitly. A calprotectin of 220 μg/g interpreted against a general-population reference reads very differently than the same value interpreted against a documented athlete-specific rested-in-training band of 80–160 μg/g.

Confounders That Change the Read

Four confounders routinely shift the paired-marker pattern in athletes and belong in the RD's intake questionnaire:

NSAID exposure. Ibuprofen and naproxen produce a dose-dependent enteropathy that raises fecal calprotectin within days of use and can persist for 2–4 weeks after discontinuation. Athletes chronically self-medicating for training soreness routinely present with calprotectin in the 150–400 μg/g band from NSAID exposure alone. Quantify: which drug, what dose, how many days in the preceding 6 weeks. "Occasional Advil" is not a data point.

Proton pump inhibitors. PPI use shifts the gut microbiome and can modestly elevate calprotectin independent of inflammation. Uncommon in the athlete population but worth capturing.

Recent GI infection. A viral or bacterial gastroenteritis in the preceding 4–8 weeks can leave calprotectin elevated well after clinical symptoms resolve. Ask about travel, food-poisoning episodes, family sick contacts, and any antibiotic courses in the workup window.

Menstrual bleeding contamination. Female athletes should not submit stool samples during menses — blood contamination can artifactually elevate both markers on some assay platforms.

The SOAP Documentation Structure That Prevents the Missed Read

The Subjective section captures the symptom timeline with specificity — not "occasional bloody stools" but "3 episodes of bright red streaking on toilet paper in the 30 minutes after long runs over 3 hours in the past 3 weeks, no bleeding on rest days or shorter sessions, no dark or melena stools reported." Frequency, timing relative to training, character of the bleeding, and any interim triggers (NSAID use, new food, travel, recent illness) all belong here.

The Objective section captures the paired-marker result with the timing metadata: "Fecal calprotectin 340 μg/g (Bühlmann ELISA, sample drawn 6 days post last long run, 4 days into active recovery block, no NSAID use in preceding 14 days). Fecal lactoferrin within reference at 4.1 μg/mL. Concurrent hs-CRP 1.8 mg/L, ferritin 42 ng/mL, MCV 88, hemoglobin within reference."

The Assessment synthesizes: "Elevated calprotectin with normal lactoferrin in the setting of a documented recovery-window sample and no NSAID exposure suggests chronic low-grade mucosal neutrophil traffic that is not fully explained by exercise-associated permeability at the current training load. Ferritin sitting mid-40s in the presence of ongoing bloody streaking warrants iron-loss quantification. Differential includes subclinical IBD masked by training-induced anti-inflammatory tone, resolving post-infectious enteritis, and chronic low-grade NSAID exposure not captured in the athlete history."

The Plan section captures the coordinated action: repeat paired markers in 10 days on the same protocol, GI referral with the paired-marker result and training log attached, hold high-heat and over-3-hour sessions in the interim, add specific NSAID-exposure quantification to the intake questionnaire, and schedule a nutrition follow-up 72 hours after the GI visit to align the fueling plan with whatever the specialist recommends. Cross-reference to the [iron-status workup](/blog/iron-status-workup-in-female-athletes) framework given the mid-40s ferritin and ongoing bleeding, and to the broader [GI-distress endurance clinical workup](/blog/gi-distress-endurance-athletes-clinical-workup) for the associated hydration, heat, and pacing-protocol audit.

Where Platform Tooling Changes the Math

The bottleneck is not the interpretation. It is the timing metadata and the paired-marker tracking across a roster of athletes with overlapping recovery windows. Managing 40 endurance athletes with GI-flag screens active at any time — a normal collegiate cross-country or triathlon-club load — generates 6–12 paired-marker workups a season, each requiring precise sample-timing coordination with the athlete's training calendar and the physician's ordering schedule.

The leverage point is a clinical dashboard that surfaces the athlete's last high-load session against the pending sample date, flags GI-workup athletes whose sample timing does not meet the 96-hour minimum, and stores the paired-marker history against the training log for trend analysis across the season. Without that structure, the sample-timing discipline lives in the RD's head — and the sample-drawn-on-Wednesday failure repeats every season.

The Bottom Line

Fecal calprotectin and lactoferrin, ordered as a pair, drawn on a recovery-window sample with training-log context, are the sports RD's discriminating tool between exercise-associated permeability and an inflammatory floor that requires GI evaluation. The general-population reference bands do not apply in isolation. The paired-marker pattern, the 96-hour timing discipline, the NSAID-and-infection confounder audit, and the SOAP documentation that captures the reasoning are what separate a clean workup from a missed IBD diagnosis or an unnecessary scope.

If your current GI workup for an endurance athlete stops at CBC and CMP, you are reading a screen that was designed for a population your athlete is not in. Build the paired-marker discipline into your intake questionnaire, coordinate the sample timing with the physician's order, and document the paired result with training context every time.

[Calsanova's Dietitian plan](/signup?role=dietitian) surfaces high-load training sessions against pending GI-workup sample windows, tracks paired-marker history alongside the athlete's food log and training data, and builds the timing metadata into the SOAP note automatically. Start your 30-day free trial and tighten the workup that primary care was not built to run.